Suchergebnisse - "Plesescu, Mihaela"

PubPharm (25)

1

Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2020

von Kato, S. | Shah, A. | Plesescu, M. | +4

2

Biotransformation of [14C]-ixazomib in patients with advanced solid tumors : characterization of metabolite profiles in plasma, urine, and feces

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Pusalkar, S. | Plesescu, M. | Gupta, N. | +6

3

Biotransformation of [14C]-ixazomib in patients with advanced solid tumors: characterization of metabolite profiles in plasma, urine, and feces

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Pusalkar, S. | Plesescu, M. | Gupta, N. | +6

4

Biotransformation of [14C]-ixazomib in patients with advanced solid tumors: characterization of metabolite profiles in plasma, urine, and feces

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Pusalkar, S. | Plesescu, M. | Gupta, N. | +6

5

Biotransformation of [14C]-ixazomib in patients with advanced solid tumors: characterization of metabolite profiles in plasma, urine, and feces

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Pusalkar, S. | Plesescu, M. | Gupta, N. | +6

6

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2018

von Gupta, N. | Zhang, S. | Pusalkar, S. | +8

7

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Gupta, N. | Zhang, S. | Pusalkar, S. | +8

8

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Gupta, N. | Zhang, S. | Pusalkar, S. | +8

9

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Gupta, N. | Zhang, S. | Pusalkar, S. | +8

10

Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles

enthalten in: Bioorganic & medicinal chemistry letters | 2016

von Li, Y. | Woo, J. | Chmielecki, J. | +7